![Mark Eisner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Eisner
Direktor/Vorstandsmitglied bei
ZURA BIO LIMITED
Vermögen: 130 167 $ am 30.06.2026
Profil
Dr. Mark Eisner, MD, ist ein Chief Medical Officer bei FibroGen, Inc. Dr. Eisner war zuvor als Senior Vice President bei Genentech, Inc. und als Professor an der University of California, San Francisco, tätig. Er erhielt seinen Bachelor-Abschluss von der Stanford University, einen Doktortitel von der UC Berkeley School of Public Health und einen Doktortitel vom University of Pennsylvania Medical Center.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
VIR BIOTECHNOLOGY, INC. 0,01 % | 31.03.2026 | 12.774 ( 0,01 % ) | 130 167 $ | 30.06.2026 |
| 25.06.2026 | 0 ( -.--% ) | - $ | 30.06.2026 | |
| 17.06.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
Aktive Positionen von Mark Eisner
| Unternehmen | Position | Beginn |
|---|---|---|
| ZURA BIO LIMITED | Direktor/Vorstandsmitglied | 21.02.2026 |
| JADE BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 25.06.2026 |
The Genentech Foundation
 The Genentech Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Mark Eisner
| Unternehmen | Position | Ende |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Technik-/Wissenschafts-/F&E-Leiter | 24.04.2026 |
Sonoma Biotherapeutics, Inc.
 Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in research, development and manufacturing cell and genetic therapy for autoimmune and degenerative diseases | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2024 |
| KYNTRA BIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | 08.09.2023 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ausbildung von Mark Eisner
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
15
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FibroGen, Inc.
 FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs | Health Technology |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Genentech Foundation
The Genentech Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
UC Berkeley School of Public Health
 UC Berkeley School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania Medical Center
 University of Pennsylvania Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vir Biotechnology, Inc.
 Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Aerovate Therapeutics, Inc.
 Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Sonoma Biotherapeutics, Inc.
Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in research, development and manufacturing cell and genetic therapy for autoimmune and degenerative diseases | Health Technology |
Zura Bio Ltd.
 Zura Bio Ltd. BiotechnologyHealth Technology Operates as a multi-asset clinical-stage biotechnology company that focuses on develops novel medicines for immune and inflammatory disorders | Health Technology |
